Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast

Abstract

Necrosis is a common feature of invasive carcinoma of the breast and is caused by chronic ischaemia leading to infarction. Although necrosis was previously assumed to be due to a generally poor blood supply in the tumour, in this study we show that it is present in tumours with focal areas of high vascular density situated away from the actual sites of necrosis. This may account, in part, for the previous observation that necrosis is linked to poor prognosis in this disease. Highly angiogenic tumours often display blood vessel shunting from one tumour area to another, which further exacerbates ischaemia and the formation of tumour necrosis. We have recently demonstrated that high focal microphage infiltration into breast tumours is significantly associated with increased tumour angiogenesis and poor prognosis and that the macrophages accumulate in poorly vascularized, hypoxic areas within breast tumours. In order to investigate the interactions of macrophages with chronic ischaemia (as reflected by the presence of necrosis) and angiogenesis in breast tumours, we quantified the levels of these three biological parameters in a series of 109 consecutive invasive breast carcinomas. We found that the degree of tumour necrosis was correlated with both microphage infiltration (Mann-Whitney U, P-value = 0.0009; chi-square, P-value = 0.01) and angiogenesis (Mann-Whitney U P-value = 0.0008, chi square P-value = 0.03). It was also observed that necrosis was a feature of tumours possessing an aggressive phenotype, i.e. high tumour grade (chi-square, P-value < 0.001), larger size (Mann-Whitney U, P-value = 0.003) and low oestrogen receptor status (Mann-Whitney U, P-value = 0.008; chi-square, P-value < 0.008). We suggest, therefore, that aggressive tumours rapidly outgrow their vascular supply in certain areas, leading to areas of prolonged hypoxia within the tumour and, subsequently, to necrosis. This, in turn, may attract macrophages into the tumour, which then contribute to the angiogenic process, giving rise to an association between high levels of angiogenesis and extensive necrosis.

References 18

1. 1.

   Blood C. H., Zetter B. R. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta. 1990;1032(1):89-118.

   Not in our library10.1016/0304-419x(90)90014-r

2. 2.

   Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P. C., Pan Y. C., Olander J. V., Connolly D. T., Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990;172(6):1535-1545.

   Not in our library10.1084/jem.172.6.1535

3. 3.

   Dachs G. U., Stratford I. J. The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br J Cancer Suppl. 1996;27:S126-S132.

   Not in our library

4. 4.

   Fisher E. R., Anderson S., Redmond C., Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer. 1993;71(8):2507-2514.

   Not in our library10.1002/1097-0142(19930415)71:8<2507::aid-cncr2820710813>3.0.co;2-0

5. 5.

   Forsythe J. A., Jiang B. H., Iyer N. V., Agani F., Leung S. W., Koos R. D., Semenza G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16(9):4604-4613.

   Not in our library10.1128/mcb.16.9.4604

6. 6.

   Fox S. B., Leek R. D., Weekes M. P., Whitehouse R. M., Gatter K. C., Harris A. L. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol. 1995;177(3):275-283.

   Not in our library10.1002/path.1711770310

7. 7.

   Harmey J. H., Dimitriadis E., Kay E., Redmond H. P., Bouchier-Hayes D. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann Surg Oncol. 1998;5(3):271-278.

   Not in our library10.1007/bf02303785

8. 8.

   Helmlinger G., Yuan F., Dellian M., Jain R. K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med. 1997;3(2):177-182.

   Not in our library10.1038/nm0297-177

9. 9.

   Kato T., Kimura T., Miyakawa R., Tanaka S., Fujii A., Yamamoto K., Kameoka S., Hamano K., Kawakami M., Aiba M. Clinicopathologic study of angiogenesis in Japanese patients with breast cancer. World J Surg. 1997;21(1):49-56.

   Not in our library10.1007/s002689900192

10. 10.

    Lee A. H., Happerfield L. C., Bobrow L. G., Millis R. R. Angiogenesis and inflammation in invasive carcinoma of the breast. J Clin Pathol. 1997;50(8):669-673.

    Not in our library10.1136/jcp.50.8.669

11. 11.
    Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma · 1998

    No notice
12. 12.

    Leek R. D., Lewis C. E., Whitehouse R., Greenall M., Clarke J., Harris A. L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996;56(20):4625-4629.

    Not in our library

13. 13.

    Lewis C. E., Leek R., Harris A., McGee J. O. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol. 1995;57(5):747-751.

    Not in our library10.1002/jlb.57.5.747

14. 14.

    Negus R. P., Stamp G. W., Hadley J., Balkwill F. R. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol. 1997;150(5):1723-1734.

    Not in our library

15. 15.

    Nicholson S., Sainsbury J. R., Needham G. K., Chambers P., Farndon J. R., Harris A. L. Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer. 1988;42(1):36-41.

    Not in our library10.1002/ijc.2910420108

16. 16.

    Plate K. H., Warnke P. C. Vascular endothelial growth factor. J Neurooncol. 1997;35(3):365-372.

    Not in our library10.1023/a:1005845307160

17. 17.

    Scannell G., Waxman K., Kaml G. J., Ioli G., Gatanaga T., Yamamoto R., Granger G. A. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res. 1993;54(4):281-285.

    Not in our library10.1006/jsre.1993.1044

18. 18.

    Semenza G. L., Roth P. H., Fang H. M., Wang G. L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269(38):23757-23763.

    Not in our library

Cited by papers we hold 8

• Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer · 2021
  No notice
• Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk · 2020
  Not checked
• Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses · 2015
  No notice
• Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting · 2015
  No notice
• Macrophages are recruited to hypoxic tumor areas and acquire a Pro-Angiogenic M2-Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin · 2014
  No notice
• Relationship between Tumor Heterogeneity Measured on FDG-PET/CT and Pathological Prognostic Factors in Invasive Breast Cancer · 2014
  No notice
• Irradiation Promotes an M2 Macrophage Phenotype in Tumor Hypoxia · 2012
  No notice
• Hypoxia Potentiates Glioma-Mediated Immunosuppression · 2011
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.